1082O KEYMAKER-U02 substudy 02C: Neoadjuvant pembrolizumab (pembro) and investigational agents followed by adjuvant pembro for stage IIIB-D melanoma

Authors: Georgina V. Long, C. Robert, Andrew Hill, C. Gaudy Marqueste, David C. Portnoy, Roni Shapira, Joel E. Cohen, Muhammad A. Khattak, C. Lebbe, Alexander M. Menzies, Gal Markel, Gil Bar‐Sela, W.H. Sharfman, C. Pagès, O. Hamid, Janice M. Mehnert, N. Jing, M. Kalabis, C. Krepler, R. Dummer - Annals of Oncology 2024 cited by 8